| BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 | ||||
| Theme: Rethinking the Next Big Things in Pharma Innovations | ||||
| Time: August 16-19, 2018 Place: Boston Marriott Cambridge, USA |
||||
| Scientific Program | ||||
| Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
| Stream 3: Industrial Art Gallery -Arts in Billion Dollar Molecules and Next Generation Therapy |
Substream 3-1: Improved Linear Drug Discovery on Selected Current Drug Targets Substream 3-6: Clinical Trial Gateway and Translational Convergence |
| Substream 3-2: Novel Small Molecule Agonists and Inhibitors |
|||
|
Session 3201: Novel Small Molecule Agonists and Inhibitors Day 1: Afternoon, Thursday, August 16, 2018 Place: Concept Room, 2nd Floor 13:30-17:10 |
|||
| Chair: Dr. Wei-Sheng Huang, Senior Director, Theseus Pharmaceuticals, USA Co-Chair: Dr. Alexei G. Basnakian, Professor, University of Arkansas for Medical Sciences, USA |
|||
| Time | FaceOn | Speeches and Speakers | |
| 13:30-13:35 | Chair's Introduction | ||
| 13:35-13:55 |  |
Title: Tackling Mutation-based Resistance in Kinase Drug Discovery: Brigatinib and AP32788 Dr. Wei-Sheng Huang, Senior Director, Theseus Pharmaceuticals, USA |
|
| 13:55-14:15 |  |
Title: The Role of F11R Antagonists in Neointimal Hyperplasia in Dialysis Vascular Accesses Dr. Moro O. Salifu, Chair, Department of Medicine; Chief, Division of Nephrology, State University of New York Downstate Medical Center, USA |
|
| 14:15-14:35 |  |
Title: Discovering Drug Leads by Practical NMR Strategies Dr. Steven LaPlante, Professor, University of Quebec INRS-IAF; Founder, NMX Research and Solutions Inc., Canada |
|
| 14:35-14:55 |  |
Title: Glucose Transporter (GLUTs) Inhibitors as Novel Anticancer Therapeutics
Dr. Xiaozhuo Chen, Associate Professor, Ohio University, USA |
|
| 14:55-16:15 |  |
Title: NSP4: The Fourth Player at the Neutrophils Serine Proteases Table Dr. Marcin Sienczyk, Assistant Professor, Wroclaw University of Science and Technology, Poland |
|
| 15:15-15:30 | Coffee Break | ||
| 15:30-15:50 |  |
Title: Discovery of Endonuclease Inhibitors - A New Class of Drugs to Combat Tissue Injury Dr. Alexei G. Basnakian, Professor, University of Arkansas for Medical Sciences, USA |
|
| 15:50-16:10 |  |
Title: Discovery of Novel Competitive GSK3 Beta Inhibitors for the Treatment of Mood Disorders
|
|
| 16:10-16:30 |  |
Title: Scaffold Synthesis of Fluorescence Alkaloid Ageladine A, an Anticancer MMP-2 Inhibitor Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan |
|
| 16:30-16:50 |  |
Title: Synthesis, Biological Evaluation and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors Dr. Reema Abu Khalaf, Associate Professor, Al-Zaytoonah University of Jordan, Jordan |
|
| 16:50-17:10 |  |
Title: MERTK Promotes Wild-type EGFR NSCLCs Resistant to Irreversible EGFR TKIs Dr. Dan Yan, Instructor, Emory University, USA |
|
| 17:30-20:30 | Welcome Banquet & Art Performance | ||
© 2003-2018 All rights reserved by BITeomics Inc. |